Ivermectin: a potent new antiparasitic agent (1983)

Peer-Reviewed Study · Campbell WC, Fisher MH, Stapley EO, Albers-Schonberg G, Jacob TA · August 26, 1983

Campbell WC et al., 1983-08-26: Merck's review of ivermectin's origin, spectrum and mechanism at the point of veterinary commercialisation.

Ivermectin is the 22,23-dihydro derivative of avermectin B1, a macrocyclic lactone produced by an actinomycete, Streptomyces avermitilis.

823

Campbell WC et al., 1983-08-26: Merck's review of ivermectin's origin, spectrum and mechanism at the point of veterinary commercialisation. C1 Campbell 1983. Study type: review. Country: USA (Merck Institute for Therapeutic Research). Funder: not stated; all authors Merck employees. Conflicts: none declared. Also states that human studies were then preliminary: 'it is not yet known whether ivermectin will be useful in human medicine.' Study type: review.